Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review
Abstract Complement-mediated thrombotic microangiopathies (CM-TMA) are rare and life-threatening disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage. These conditions result from dysregulation of the alternative complement pathway, often due to genetic va...
Saved in:
| Main Author: | Pilar Musalem |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-025-04080-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atypical Hemolytic Uremic Syndrome in a Postoperative Patient: Diagnostic Challenges and Therapeutic Strategies
by: Ayda Fathollah Pour, et al.
Published: (2025-06-01) -
Clinical characteristics and genetic profile of complement system in renal thrombotic microangiopathy in patients with severe forms of arterial hypertension
by: Mariam I. Akaeva, et al.
Published: (2024-01-01) -
Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies
by: Manuel Urra, et al.
Published: (2024-08-01) -
High prevalence of the hotspot complement factor I p.Ile357Met pathogenic variant in Tunisian atypical hemolytic uremic syndrome patients: report of three new cases and review of the literature
by: Asma Tajouri, et al.
Published: (2025-08-01) -
Complement-mediated hemolytic uremic syndrome associated with postpartum hemorrhage: case series and systematic review of individual participant data
by: Anna Gurevich-Shapiro, et al.
Published: (2024-11-01)